No Data
No Data
Is Ocular Therapeutix (NASDAQ:OCUL) Using Debt Sensibly?
BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Xencor (XNCR) and GeneDx Holdings (WGS)
Earnings Preview: OCUL to Report Financial Results Pre-market on May 05
Ocular Therapeutix to Participate in Upcoming Investor and Scientific Conferences
Ocular Therapeutix to Report First Quarter 2025 Financial Results on May 5, 2025
70581059 : a great buying opportunity in general. if the tariff stays, it has already been priced in. in case not, it will surge back.